231 related articles for article (PubMed ID: 26151427)
1. MicroRNA‑21 regulates the expression of BTG2 in HepG2 liver cancer cells.
Mao B; Xiao H; Zhang Z; Wang D; Wang G
Mol Med Rep; 2015 Oct; 12(4):4917-24. PubMed ID: 26151427
[TBL] [Abstract][Full Text] [Related]
2. [The relationship between microRNA-18 and BTG2 in the carcinogenesis of hepatocellular carcinoma].
Li Q; Wang G; Zhang ZM
Zhonghua Gan Zang Bing Za Zhi; 2009 Jan; 17(1):42-5. PubMed ID: 19203451
[TBL] [Abstract][Full Text] [Related]
3. MiR-6875-3p promotes the proliferation, invasion and metastasis of hepatocellular carcinoma via BTG2/FAK/Akt pathway.
Xie Y; Du J; Liu Z; Zhang D; Yao X; Yang Y
J Exp Clin Cancer Res; 2019 Jan; 38(1):7. PubMed ID: 30621734
[TBL] [Abstract][Full Text] [Related]
4. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
Wu WL; Wang WY; Yao WQ; Li GD
Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
[TBL] [Abstract][Full Text] [Related]
5. BTG2 loss and miR-21 upregulation contribute to prostate cell transformation by inducing luminal markers expression and epithelial-mesenchymal transition.
Coppola V; Musumeci M; Patrizii M; Cannistraci A; Addario A; Maugeri-Saccà M; Biffoni M; Francescangeli F; Cordenonsi M; Piccolo S; Memeo L; Pagliuca A; Muto G; Zeuner A; De Maria R; Bonci D
Oncogene; 2013 Apr; 32(14):1843-53. PubMed ID: 22614007
[TBL] [Abstract][Full Text] [Related]
6. Aberrant expression of the p53-inducible antiproliferative gene BTG2 in hepatocellular carcinoma is associated with overexpression of the cell cycle-related proteins.
Zhang Z; Chen C; Wang G; Yang Z; San J; Zheng J; Li Q; Luo X; Hu Q; Li Z; Wang D
Cell Biochem Biophys; 2011 Sep; 61(1):83-91. PubMed ID: 21327578
[TBL] [Abstract][Full Text] [Related]
7. Expression and function of microRNA-27b in hepatocellular carcinoma.
He S; Zhang J; Lin J; Zhang C; Sun S
Mol Med Rep; 2016 Mar; 13(3):2801-8. PubMed ID: 26846382
[TBL] [Abstract][Full Text] [Related]
8. BTG2 Is Down-Regulated and Inhibits Cancer Stem Cell-Like Features of Side Population Cells in Hepatocellular Carcinoma.
Huang CS; Zhai JM; Zhu XX; Cai JP; Chen W; Li JH; Yin XY
Dig Dis Sci; 2017 Dec; 62(12):3501-3510. PubMed ID: 29098552
[TBL] [Abstract][Full Text] [Related]
9. Circular RNA circFLNA inhibits the development of bladder carcinoma through microRNA miR-216a-3p/BTG2 axis.
Lin S; Wang L; Shi Z; Zhu A; Zhang G; Hong Z; Cheng C
Bioengineered; 2021 Dec; 12(2):11376-11389. PubMed ID: 34852712
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma.
Liu M; Wu H; Liu T; Li Y; Wang F; Wan H; Li X; Tang H
Cell Res; 2009 Jul; 19(7):828-37. PubMed ID: 19546886
[TBL] [Abstract][Full Text] [Related]
11. Impact of BTG2 expression on proliferation and invasion of gastric cancer cells in vitro.
Zhang L; Huang H; Wu K; Wang M; Wu B
Mol Biol Rep; 2010 Jul; 37(6):2579-86. PubMed ID: 19728149
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA‑21 expression is associated with the clinical features of patients with gastric carcinoma and affects the proliferation, invasion and migration of gastric cancer cells by regulating Noxa.
Sun H; Wang P; Zhang Q; He X; Zai G; Wang X; Ma M; Sun X
Mol Med Rep; 2016 Mar; 13(3):2701-7. PubMed ID: 26847916
[TBL] [Abstract][Full Text] [Related]
13. miRNA‑222 promotes liver cancer cell proliferation, migration and invasion and inhibits apoptosis by targeting BBC3.
Liu Z; Sun J; Liu B; Zhao M; Xing E; Dang C
Int J Mol Med; 2018 Jul; 42(1):141-148. PubMed ID: 29693134
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effects of B‑cell translocation gene 2 on skin cancer cells via the Wnt/β‑catenin signaling pathway.
Gao SS; Yang XH; Wang M
Mol Med Rep; 2016 Oct; 14(4):3464-8. PubMed ID: 27510158
[TBL] [Abstract][Full Text] [Related]
15. Expression and significance of miRNA-21 and BTG2 in lung cancer.
Sun Q; Hang M; Guo X; Shao W; Zeng G
Tumour Biol; 2013 Dec; 34(6):4017-26. PubMed ID: 23857284
[TBL] [Abstract][Full Text] [Related]
16. miR‑27a suppresses the clonogenic growth and migration of human glioblastoma multiforme cells by targeting BTG2.
Li WQ; Yu HY; Zhong NZ; Hou LJ; Li YM; He J; Liu HM; Xia CY; Lu YC
Int J Oncol; 2015 Apr; 46(4):1601-8. PubMed ID: 25626081
[TBL] [Abstract][Full Text] [Related]
17. microRNA-141 inhibits cell proliferation and invasion and promotes apoptosis by targeting hepatocyte nuclear factor-3β in hepatocellular carcinoma cells.
Lin L; Liang H; Wang Y; Yin X; Hu Y; Huang J; Ren T; Xu H; Zheng L; Chen X
BMC Cancer; 2014 Nov; 14():879. PubMed ID: 25425543
[TBL] [Abstract][Full Text] [Related]
18. Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer.
Jalava SE; Urbanucci A; Latonen L; Waltering KK; Sahu B; Jänne OA; Seppälä J; Lähdesmäki H; Tammela TL; Visakorpi T
Oncogene; 2012 Oct; 31(41):4460-71. PubMed ID: 22266859
[TBL] [Abstract][Full Text] [Related]
19. PRMT5 promotes cell proliferation by inhibiting BTG2 expression via the ERK signaling pathway in hepatocellular carcinoma.
Jiang H; Zhu Y; Zhou Z; Xu J; Jin S; Xu K; Zhang H; Sun Q; Wang J; Xu J
Cancer Med; 2018 Mar; 7(3):869-882. PubMed ID: 29441724
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of microRNA-210 inhibits proliferation of hepatocellular carcinoma cells by targeting YES1.
Tan W; Lim SG; Tan TM
World J Gastroenterol; 2015 Dec; 21(46):13030-41. PubMed ID: 26676187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
